Cognizant to provide comprehensive approach to adopting AI

By Liza Laws

- Last updated on GMT

© Getty Images
© Getty Images

Related tags Artificial intelligence Data management AI machine learning Patient centricity

Cognizant has announced a platform that can use it consulting, advisory, ecosystem partnership along with digital studios and industry knowledge to help its clients transition to generative artificial intelligence (AI).

The platform called Cognizant Neuro AI, the company says, has been designed to give a comprehensive approach to speed up the adoption time of AI while using its business value in a flexible, secure, scalable and responsible way.

Cognizant says it is among the first to launch an enterprise-wide generative AI platform designed to help clients better understand, consume, and customize AI models that drive business outcomes.

“It is fast becoming clear that businesses must embrace AI without delay to remain competitive,” said Prasad Sankaran, EVP of Cognizant’s software and platform engineering.

“This is an exciting moment, as Cognizant’s Neuro AI platform goes beyond proof of concept, aiming to accelerate the adoption of enterprise scale AI applications, increase ROI potential, minimize risks and get to better business solutions, faster.”

Cognizant says its platform will guide firms on this journey, from identifying company specific-use cases and operationalizing AI, to data engineering and continuous improvement. It enables AI and software engineering teams to build flexible, reusable, safe and secure solutions, and design conversational and generative user experiences, embedding AI models to create fully functioning apps – all supported across multi-platform, multi-cloud ecosystems. 

The company says the launch of Cognizant Neuro AI builds on years of AI research, development, and client-facing commercial AI applications. This includes deep learning, evolutionary AI, and deploying generative AI techniques in industries like life sciences, retail, and healthcare.

The company’s AI teams have enabled AI-guided decisions in areas such as price optimization, predictive healthcare analytics and crop science optimization. Business leaders gain access to the full range of tools and capabilities, fostering human-AI collaboration on an enterprise-wide platform.

Anna Elango, EVP of Cognizant’s core technologies and insights, said: “We believe enterprises need scalable, flexible, end-to-end tools to accelerate responsible AI adoption.

“By partnering human expertise, including Cognizant’s deep industry insights, with the power of generative AI, we aim to help our clients catalyze informed decisions and tackle complex business challenges to drive cost efficiencies, resilience and business revenue.”

Cognizant Neuro AI includes a library of reusable generative AI models and agents, development tooling and control components including API and access management, versioning and auditing. The company says its platform is designed to provide meaningful business benefits for clients, including discovering new business innovation vectors, creating pathways to differentiated customer and employee experiences, the ability to reimagine and digitize business processes, and reliable governance, visibility, control and compliance.

Related news

Show more

Related products

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Product Brochure

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Related suppliers